Cochrane · systematic review · CD008933
Immunomodulators and immunosuppressants for multiple sclerosis: a network meta‐analysis
Filippini, G, Del Giovane, C, Vacchi, L, et al. · Cochrane Database of Systematic Reviews · 2013 · Cochrane Library
Multiple Sclerosis and Rare Diseases of the CNSAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
7
current version
GRADE rated
0
No studies
7
Included studies
NR
No studies 7 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Summary of findings table
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Comparison intervention | no estimate extracted | NR | No studies |
placebo | no estimate extracted | NR | No studies |
IFNß‐1a (Avonex) | no estimate extracted | NR | No studies |
IFNß‐1a (Rebif) | no estimate extracted | NR | No studies |
IFNß‐1b (Betaseron) | no estimate extracted | NR | No studies |
Glatiramer acetate | no estimate extracted | NR | No studies |
IFNß‐1a Avonex | no estimate extracted | NR | No studies |